ENMC Company Forum

Sanofi_Genzyme_RGB_Colors.jpg  logo_Santhera.gif      Amicus_logo.png       






In the last decade, the number of clinical trials for neuromuscular disorders steadily increased. For some diseases, the first treatments are being expected to be made available to patients in the next few years. However, there is still much to do:

  • The existing technologies require optimisation
  • Clinical trial readiness needs further improvement
  • International consensus of best practice care guidelines needs to be reached and implemented for all rare neuromuscular conditions.

This is also reflected in the increased number of applications submitted to the ENMC. In 2015, the ENMC started the initiative of the ENMC Company Forum, which members are pharmaceutical and biotech companies with neuromuscular disorders as one of their areas of interest. The Company Forum supports us to respond to the increasing demand for ENMC workshops and thereby facilitating collaboration between key opinion leaders working in the field of neuromuscular disease worldwide.

What does a membership entail?

With a membership in the ENMC Company Forum, companies will co-sponsor all ENMC workshops. Members of this forum will be associated with the mission and the heritage of the ENMC. The forum follows the international guidelines regarding inducements and sponsorship. 

Click here for more information about the Code of Conduct and the Membership Benefits

If you have any questions regarding the Company Forum and/or your organisation considers a membership in the ENMC Company Forum, please don't hesitate to contact us at enmc@enmc.org or +31-35-5480482

Current members of the ENMC Company Forum

The ENMC kindly acknowledges the generous support of the following Company Forum members: